Related Experiment Video

Updated: Aug 11, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

Therapeutic advantage of angiotensin converting enzyme inhibitors in chronic glomerulonephritis

K Omata1, T Saito, H Sato

  • 12nd Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan. omatak2i@mail.cc.tohoku.ac.jp

Immunopharmacology
|December 22, 1999
PubMed

Insights

Maintaining optimal ambulatory blood pressure (ABP) is crucial for slowing kidney function decline in chronic progressive renal disease. Specific ABP ranges, varying by age, were identified to improve or slow the loss of renal function in patients with chronic glomerulonephritis.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Hypertension is a significant factor in chronic progressive renal disease, accelerating kidney function loss.
  • Managing blood pressure is critical for preserving renal function in patients with kidney disease.

Purpose of the Study:

  • To investigate the influence of ambulatory blood pressure (ABP) on renal function in patients with chronic glomerulonephritis.
  • To evaluate the effects of hypertension therapy on renal function in this patient group.

Main Methods:

  • 116 patients with chronic glomerulonephritis were studied.
  • Patients were categorized into hypertensive, normotensive, and hypotensive groups based on ABP and age.
  • Renal function and urinary protein excretion were monitored.

Main Results:

  • Hypotensive subjects demonstrated improved renal function.
  • Normotensive subjects experienced a slower rate of renal function decline compared to hypertensive subjects.
  • Specific age-dependent ABP ranges were suggested for optimal renal protection.
  • Calcium antagonists' renal protection correlated with lower blood pressure, while ACE inhibitors showed reduced urinary protein excretion independently of blood pressure levels.

Conclusions:

  • Adequate ambulatory blood pressure levels, tailored to age, are essential for preserving renal function in chronic glomerulonephritis.
  • The mechanisms of renal protection differ between ACE inhibitors and calcium antagonists.
  • ACE inhibitors offer renal protection partly through reducing urinary protein excretion, a benefit not observed with calcium antagonists.

More Related Videos

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Related Concept Videos

Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...